Stockscreener 앱 받기
13.72
1.79%
-0.25
시간 외 거래:
13.74
0.02
+0.15%
전일 마감가:
$13.97
열려 있는:
$14.01
하루 거래량:
823.94K
Relative Volume:
0.98
시가총액:
$648.06M
수익:
$840.00K
순이익/손실:
$-75.20M
주가수익비율:
-8.6175
EPS:
-1.5921
순현금흐름:
$-65.69M
1주 성능:
+14.81%
1개월 성능:
+40.72%
6개월 성능:
+208.31%
1년 성능:
+143.69%
1일 변동 폭
$13.44
$14.22
1주일 범위
$13.36
$17.58
52주 변동 폭
$4.19
$17.58
Silence Therapeutics Plc Adr Stock (SLN) Company Profile
명칭
Silence Therapeutics Plc Adr
전화
44-0-20-3457 6900
주소
12 HAMMERSMITH GROVE, LONDON
Compare SLN vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLN
Silence Therapeutics Plc Adr
|
13.72 | 641.45M | 840.00K | -75.20M | -65.69M | -1.5921 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Silence Therapeutics Plc Adr Stock (SLN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-11 | 개시 | Goldman | Sell |
| 2024-12-02 | 재확인 | BMO Capital Markets | Outperform |
| 2024-09-03 | 개시 | Jefferies | Buy |
| 2024-01-31 | 개시 | BMO Capital Markets | Outperform |
Silence Therapeutics Plc Adr 주식(SLN)의 최신 뉴스
Silence Therapeutics closes $201.3M public offering By Investing.com - Investing.com India
Silence Therapeutics closes $201.3M public offering - Investing.com
Wall Street Analysts Predict a 140.06% Upside in Silence Therapeutics (SLN): Here's What You Should Know - Yahoo Finance
Silence Therapeutics Announces Pricing of $13.50 Per ADS in Public Offering - Kalkine Media
Form 8K Silence Therapeutics plc For: 12 August By Investing.com - Investing.com India
Silence Therapeutics (NASDAQ:SLN) Shares Down 6.9%What's Next? - marketbeat.com
Silence Therapeutics prices $175M public offering at $13.50 per ADS - Investing.com
Why Avalon Holdings Shares Are Trading Higher By More Than 10%; Here Are 20 Stocks Moving Premarket - Sahm
Silence Therapeutics (NASDAQ:SLN) Sees Unusually-High Trading VolumeWhat's Next? - marketbeat.com
Silence Therapeutics’ Divesiran Hits Phase II Goal, Sets Up Phase III PV Trial - sharewise.com
Silence Therapeutics Jumps Over 25% After Divesiran Phase 2 Trial Supports 12-Week Dosing - TechStock²
Silence Therapeutics launches $150 million public offering - Investing.com
Silence Therapeutics launches $150 million public offering By Investing.com - Investing.com India
Silence Therapeutics (NASDAQ:SLN) Shares Gap UpStill a Buy? - marketbeat.com
Silence Therapeutics Reports Q2 2026 Financial Results in SEC Filing - Kalkine Media
Silence Therapeutics Announces Positive Phase 2 SANRECO Trial Outcomes for Divesiran in Polycythemia Vera - Kalkine Media
Silence Therapeutics SLN Stock Heats Up Ahead Phase 2 Data - StocksToTrade
Silence Therapeutics (SLN) Rallies Ahead Of Key Phase 2 Data - timothysykes.com
Silence Therapeutics reports positive phase 2 trial results - Investing.com
Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile - Finviz
Why is Silence Therapeutics stock surging today? By Investing.com - Investing.com South Africa
Silence Therapeutics (NASDAQ:SLN) Reaches New 1-Year HighStill a Buy? - MarketBeat
Silence Therapeutics PLC Sponsored ADR (NASDAQ:SLN) Given Consensus Rating of "Moderate Buy" by Brokerages - marketbeat.com
ADAR1 Capital Management LLC Buys 148,514 Shares of Silence Therapeutics PLC Sponsored ADR $SLN - marketbeat.com
Silence Therapeutics (NASDAQ:SLN) Sees Large Volume IncreaseStill a Buy? - marketbeat.com
Silence Therapeutics (NASDAQ:SLN) Reaches New 12-Month HighTime to Buy? - marketbeat.com
Silence Therapeutics (NASDAQ:SLN) Stock Price Up 6.9%Here's Why - marketbeat.com
SLN stock skyrockets 107% in six months: Here's what you need to know - MSN
Silence Therapeutics (SLN) moves 7.2% higher: Will this strength last? - MSN
ETFs Investing in Silence Therapeutics PLC Sponsored ADR Stocks - TradingView
SLN Stock Skyrockets 107% in Six Months: Here's What You Need to Know - Yahoo Finance UK
Silence Therapeutics (SLN) Moves 7.2% Higher: Will This Strength Last? - Yahoo Finance Singapore
Silence Therapeutics (NASDAQ:SLN) Shares Up 10%Here's What Happened - MarketBeat
Form 13D/A Silence Therapeutics Plc For: 8 July By Investing.com - Investing.com South Africa
Silence Therapeutics (SLN) surges 26.0%: Is this an indication of further gains? - MSN
Silence Therapeutics PLC Sponsored ADR Actuals & Estimates (NASDAQ:SLN) - TradingView
Silence Therapeutics (SLN) Surges 26.0%: Is This an Indication of Further Gains? - Yahoo Finance Singapore
Why is Silence Therapeutics stock surging today? - Investing.com
Silence Therapeutics stock jumps on Cantor Fitzgerald upgrade - Investing.com
Form 8K Silence Therapeutics plc For: 23 June By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Silence Therapeutics stock rating at buy By Investing.com - Investing.com India
H.C. Wainwright reiterates Silence Therapeutics stock rating at buy - Investing.com
Silence Therapeutics Stock Rises On Positive Blood Cancer Drug Data - Sahm
Silence Therapeutics presents divesiran trial data at EHA By Investing.com - Investing.com South Africa
Silence Therapeutics presents divesiran trial data at EHA - Investing.com
Silence Therapeutics (SLN) soars 19.0%: Is further upside left in the stock? - MSN
SLNSilence Therapeutics Plc ADR Stock Price and Quote - Finviz
Silence Therapeutics (NASDAQ: SLN) registers $300M shelf, $100M ADSs included - Stock Titan
Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference - ChartMill
Revenue per share of Silence Therapeutics PLC Sponsored ADR – DUS:XRP2 - TradingView
Book value per share of Silence Therapeutics PLC Sponsored ADR – DUS:XRP2 - TradingView
Silence Therapeutics Plc Adr (SLN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
0.07%
자본화:
|
볼륨(24시간):